GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit www.grail.com
The Associate Director, Clinical Compliance is responsible for the delivery & execution of the research compliance program audit & regulatory inspection-ready activities. This role supports compliance with good clinical practice (GCP) standards of GRAIL-sponsored, supported or funded clinical studies, including adherence to standard operating procedures (SOPs), policies, & all applicable regulations & guidelines (e.g. US FDA regulations, UK & EU clinical trial directives, & ICH standards). Will supervise & implement GCP audits of clinical study sites, vendors, & processes, ensuring compliance & regulatory inspection readiness, & handling the clinical trial related-SOP program.